The ataxia-telangiectasia mutated (ATM) gene, an oncosuppressor involved in DNA repair response pathways, is an important regulator of cell checkpoint signaling and the repair of double-stranded breaks by phosphorylating downstream proteins such as p53 and BRCA1, which are implicated in breast cancer. The gene discussed is ATM; the disease is breast cancer.